These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2203225)

  • 1. [Is there a role for immunology in the prevention of malignant tumors of the head and neck?].
    Beatrice F; Cortesina G; Succo G; Spiga G; Bessone F; Pecorari G; Sartoris A
    Acta Otorhinolaryngol Ital; 1990; 10 Suppl 27():55-8. PubMed ID: 2203225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of head and neck cancer: magnitude of the problem.
    Döbrossy L
    Cancer Metastasis Rev; 2005 Jan; 24(1):9-17. PubMed ID: 15785869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Links between alcohol misuse and cancers of the head and neck.
    Buglass E
    Prof Nurse; 1995 Sep; 10(12):789-90. PubMed ID: 7675810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for cancers of the head and neck: addressing the problem.
    Ellison MD; Campbell BH
    Surg Oncol Clin N Am; 1999 Oct; 8(4):725-34, vii. PubMed ID: 10452937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemoprevention in cancer of the head and neck].
    Sánchez Hernández A; Mesía R; Montes A; Cardenal F
    Acta Otorrinolaringol Esp; 1997; 48(1):1-4. PubMed ID: 9131918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early diagnosis and prevention of malignant tumors in the head and neck region].
    Tan IB; Roodenburg JL; Copper MP; Coebergh JW; van der Waal I
    Ned Tijdschr Geneeskd; 2001 Mar; 145(12):567-72. PubMed ID: 11293995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of cellular immunity in patients with malignant tumors].
    Niksic M; Balogh M; Jurin M
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(9-10):387-96. PubMed ID: 794967
    [No Abstract]   [Full Text] [Related]  

  • 9. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.
    Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Hsu TC; Schantz SP
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1043-9. PubMed ID: 11045786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of immunology and head and neck tumors.
    Church JM; Ryan RF
    Clin Plast Surg; 1976 Jul; 3(3):385-8. PubMed ID: 963948
    [No Abstract]   [Full Text] [Related]  

  • 11. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
    Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
    J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marijuana use and increased risk of squamous cell carcinoma of the head and neck.
    Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Marshall JR; Hsu TC; Schantz SP
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1071-8. PubMed ID: 10613339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the influence of nicotynism on selected diseases of the head and neck].
    Doroszyńska-Tomczyk M
    Przegl Lek; 2007; 64(10):642-4. PubMed ID: 18409275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-p53 antibodies in serum of smokers and head and neck cancer patients.
    Wollenberg B; Jan NV; Pitzke P; Reiter W; Stieber P
    Anticancer Res; 1997; 17(1A):413-8. PubMed ID: 9066686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
    Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
    Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck cancer State of the Art converence. Section I. Immunology.
    Baram P
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):10-1. PubMed ID: 619198
    [No Abstract]   [Full Text] [Related]  

  • 17. Quadruple cancer, including triple cancers in the head and neck region.
    Németh Z; Czigner J; Iván L; Ujpál M; Barabás J; Szabó G
    Neoplasma; 2002; 49(6):412-4. PubMed ID: 12584590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck].
    Bulbuk GA
    Vopr Onkol; 1982; 28(4):57-9. PubMed ID: 7090271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for head and neck cancer].
    Ligue nationale contre le cancer
    Rev Prat; 2006 Oct; 56(15):1692. PubMed ID: 17137256
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.